The global wound & tissue care market was valued at USD 29,336.4 mn in 2018 and is expected to reach USD 44,991.9 mn by 2025 at a CAGR of 6.3% during the forecast period.The global wound & tissue care market is witnessing growth due to increasing prevalence of diabetes, rapid growth in geriatric population, developments and innovations in wound care products, increasing funding for wound care research, and awareness programs for wound care treatment and management. Chronic conditions such as diabetic foot ulcers that are not healed and venous leg ulcers are a tremendous burden on the health care system. While a little over half of diabetic foot ulcers will cure within 12 weeks, a year after occurrence, 13 percent will stay unhealed. Medicare recipients with diabetic foot ulcers are seen approximately 12 times a year by their outpatient health care providers and they are hospitalized approximately twice a year. Approximately 1 million Americans face diabetic foot ulcers every year, equivalent to more than USD 15 billion in annual healthcare spending. Additionally, more than three million Americans experience venous leg ulcer each year, adding an additional USD 2 billion or more to the nation's healthcare expenditure. The Traditional adhesive bandages segment is expected to dominate the market throughout the forecast periodBased on the type, the market has been segmented into traditional adhesive bandages, negative pressure wound therapy, antimicrobial dressings, traditional gauze bandages, foam dressings, non-adherent bandages, hydrocolloids, film dressings, growth factors, bioengineered skin, and others. Among these, traditional adhesive bandages are dominating the market in the year 2018 and are expected to witness the same growth trend during the forecast period. In 2018, the traditional adhesive bandages segment accounted for 26.5% of the overall wound & tissue care market share and it is expected to grow at a CAGR of 5.9% over the forecast period. Sticking plasters or dressings used for tiny wounds are adhesive bandages. These bandages are used for wounds that are not severe enough to require a full-size bandage. They defend wounds against additional injuries, friction, bacteria, and dirt. They cure injuries and carry skin cuts. As medicated or non-medicated bandages, adhesive bandages are accessible. Based on applications, the surgical segment is expected to dominant the market during the forecast periodBased on applications, the market has been segmented as surgical, trauma/lacerations, burns, pressure ulcer, venous ulcer, and diabetic ulcer. Among these, the surgical segment accounts for the largest share in the global wound & tissue care market by application. Surgical care is essential for managing diverse health conditions such as injuries, obstructed labour, malignancy, infections, and cardiovascular diseases and it is an indispensable component of a functioning health system. An increasing number of surgeries worldwide are expected to drive the wound & tissue care market for surgical applications. In 2018, surgical applications accounted for more than 60% of overall market share and are expected to grow at a CAGR of 6.5% over the forecast period.North America to dominate the wound & tissue market throughout the forecast periodThe North America wound & tissue care market size is expected to grow at a CAGR of 6.2% over the forecast period. Leading wound care companies operating in North America are Ethicon, Acelity, Medtronic, Cardinal Health, Medline, Baxter, 3M, Integra LifeSciences, MiMedx, and Mölnlycke. The increasing prevalence of diabetes, ulcers, and other chronic diseases is expected to propel the wound care market in this region. Additionally, the growing aging population will further create demand for wound & tissue care services in the coming years.Company Profiles and Competitive IntelligenceThe major players operating in the global wound & tissue care market are 3M, ABL Medical, Acelity, ACell, AquaMed, Amniox Medical, Inc, Angelini, Argentum Medical, LLC, ArjoHuntleigh, Arobella Medical, LLC, Baxter International Inc., Aesculap, Inc. - B. Braun, Cardinal Health, Coloplast A/S, ConvaTec, Inc, and other notable players.
Chapter 1Executive Summary
1.1Global Wound & Tissue Care market overview
1.2Wound & Tissue Care Segment by Type
1.2.1Traditional adhesive bandages
1.2.2Negative pressure wound therapy
1.2.3Antimicrobial dressings
1.2.4Traditional gauze bandages
1.2.5Foam dressings
1.2.6Non-adherent bandages
1.2.7Hydrocolloids
1.2.8Film dressings
1.2.9Growth factors
1.2.10Bioengineered skin
1.3Wound & Tissue Care Segment by Application
1.3.1Surgical
1.3.2Trauma/Lacerations
1.3.3Burns
1.3.4Pressure ulcer
1.3.5Venous ulcer
1.3.6Diabetic ulcer
1.4Global Wound & Tissue Care Market by Region
1.4.1North America
1.4.2Europe
1.4.3China
1.4.4Japan
1.5Global Wound & Tissue Care Market Size
1.5.1Global Wound & Tissue Care Revenue (2014-2025)
Chapter 2Global Wound & Tissue Care Market Competition by Manufacturers
2.1Global Wound & Tissue Care Revenue Share by Manufacturers, 2018
2.2Manufacturers Wound & Tissue Care Sites, Area Served, Product Types
2.3Wound & Tissue Care Market Competitive Situation and Trends
2.3.1Wound & Tissue Care Market Concentration Rate
2.3.2Wound & Tissue Care Market Share of Top 3 and Top 5 Manufacturers
2.3.3Mergers & Acquisitions, Expansion, New product development
Chapter 3Company Profiles - Wound & Tissue Care Business
3.13M
3.1.1Company overview
3.1.2Product offerings
3.1.3Financial performance
3.1.4Recent developments
3.2ABL Medical
3.2.1Company overview
3.2.2Product offerings
3.3Acelity
3.3.1Company overview
3.3.2Product offerings
3.3.3Financial performance
3.3.4Recent developments
3.4ACell
3.4.1Company overview
3.4.2Product offerings
3.4.3Financial performance
3.5AquaMed - Alliqua BioMedical
3.5.1Company overview
3.5.2Product offerings
3.5.3Financial performance
3.6Amniox Medical, Inc.
3.6.1Company overview
3.6.2Product offerings
3.6.3Financial performance
3.7Angelini
3.7.1Company overview
3.7.2Product offerings
3.7.3Financial performance
3.8Argentum Medical, LLC
3.8.1Company overview
3.8.2Product offerings
3.8.3Financial performance
3.9ArjoHuntleigh
3.9.1Company overview
3.9.2Product offerings
3.9.3Financial performance
3.10Arobella Medical, LLC
3.10.1Company overview
3.10.2Product offerings
3.10.3Financial performance
3.11Baxter International Inc.
3.11.1Company overview
3.11.2Product offerings
3.11.3Financial performance
3.11.4Recent developments
3.12Aesculap, Inc. - B. Braun
3.12.1Company overview
3.12.2Product offerings
3.12.3Financial performance
3.13Cardinal Health
3.13.1Company overview
3.13.2Product offerings
3.13.3Financial performance
3.14Coloplast A/S
3.14.1Company overview
3.14.2Product offerings
3.14.3Financial performance
3.14.4Recent developments
3.15ConvaTec, Inc
3.15.1Company overview
3.15.2Product offerings
3.15.3Financial performance
3.15.4Recent developments
3.16Crawford Healthcare Ltd
3.16.1Company overview
3.16.2Product offerings
3.16.3Financial performance
3.17CryoLife, Inc.
3.17.1Company overview
3.17.2Product offerings
3.17.3Financial performance
3.18Smith & Nephew PLC
3.18.1Company overview
3.18.2Product offerings
3.18.3Financial performance
3.19Johnson & Johnson - ETHICON, INC.
3.19.1Company overview
3.19.2Product offerings
3.19.3Financial performance
3.20Integra Lifesciences
3.20.1Company overview
3.20.2Product offerings
3.20.3Financial performance
3.21MiMedx Group
3.21.1Company overview
3.21.2Product offerings
3.21.3Financial performance
Chapter 4Wound & Tissue Care Manufacturing Cost Analysis
4.1Wound & Tissue Care Key Raw Materials Analysis
4.1.1Key Raw Materials
4.1.2Price Trend of Key Raw Materials
4.1.3Key Suppliers of Raw Materials
4.2Proportion of Manufacturing Cost Structure
4.3Wound & Tissue Care Industrial Chain Analysis
Chapter 5Marketing, Distributors, and Customer
5.1Marketing Channel
5.1.1Direct Channels
5.1.2Indirect Channels
5.2Wound & Tissue Care Distributors List
5.3Wound & Tissue Care Customers
Chapter 6Market Dynamics
6.1Market Trends
6.2Opportunities
6.3Market Drivers
6.4Challenges
6.5Influence Factors
Chapter 7Global Wound & Tissue Care Market Forecast
7.1Global Wound & Tissue Care Revenue Forecast, 2019 – 2025 (USD Million)
7.1.1Global Wound & Tissue Care Revenue and Growth Rate Forecast (2019-2025)
7.2Global Wound & Tissue Care Revenue Forecast by Regions (2019-2025)
7.2.1North America Revenue Forecast (2019-2025)
7.2.2Europe Revenue Forecast (2019-2025)
7.2.3China Revenue Forecast (2019-2025)
7.2.4Japan Revenue Forecast (2019-2025)
7.3Global Wound & Tissue Care Revenue Forecast by Type (2019-2025)
7.3.1Traditional adhesive bandages Revenue Forecast (2019-2025)
7.3.2Negative pressure wound therapy Revenue Forecast (2019-2025)
7.3.3Antimicrobial dressings Revenue Forecast (2019-2025)
7.3.4Traditional gauze bandages Revenue Forecast (2019-2025)
7.3.5Foam dressings Revenue Forecast (2019-2025)
7.3.6Non-adherent bandages Revenue Forecast (2019-2025)
7.3.7Hydrocolloids Revenue Forecast (2019-2025)
7.3.8Film dressings Revenue Forecast (2019-2025)
7.3.9Growth factors Revenue Forecast (2019-2025)
7.3.10Bioengineered skin Revenue Forecast (2019-2025)
7.4Global Wound & Tissue Care Revenue Forecast by Application (2019-2025)
7.4.1Surgical Wound & Tissue Care Revenue Forecast (2019-2025)
7.4.2Trauma/Lacerations Wound & Tissue Care Revenue Forecast (2019-2025)
7.4.3Burns Wound & Tissue Care Revenue Forecast (2019-2025)
7.4.4Pressure ulcer Wound & Tissue Care Revenue Forecast (2019-2025)
7.4.5Venous ulcer Wound & Tissue Care Revenue Forecast (2019-2025)
7.4.6Diabetic ulcer Wound & Tissue Care Revenue Forecast (2019-2025)
Chapter 8Research Findings and Conclusion
Chapter 9Methodology and Data Source
9.1Methodology/Research Approach
9.1.1Phase I – Secondary Research
9.1.2Phase II – Primary Research
9.1.3Assumptions
9.1.4Market Size Estimation
9.1.4.1Top-Down Approach
9.1.4.2Bottom-Up Approach
9.2Data Source
9.2.1Secondary Source
9.3Disclaimer
TABLE 1Wound & Tissue Care Market
TABLE 2Wound & Tissue Care Revenue, By Type, 2014-2019 (USD Million)
TABLE 3Antiseptic agents and their formulation
TABLE 4Wound & Tissue Care Revenue, By Application, 2014-2019 (USD Million)
TABLE 5Wound & Tissue Care Revenue, By Application, 2014-2019 (USD Million)
TABLE 6Manufacturers Wound & Tissue Care Sites, Area Served, Product
TABLE 7Wound & Tissue Care Market Share of Top 5 Manufacturers
TABLE 8Key Raw Material Suppliers
TABLE 9Wound & Tissue Care Distributors List
TABLE 10US and worldwide wound prevalence
TABLE 11Per capita healthcare spending in 2017 in USD
TABLE 12Countries With The Elderly Population In The World
TABLE 13Global Wound & Tissue Care Revenue Forecast
TABLE 14Global Wound & Tissue Care Revenue Forecast by Regions (2019-2025) (USD Million)
TABLE 15Global Wound & Tissue Care Revenue Forecast by Regions (2019-2025) (USD Million)
TABLE 16Global Wound & Tissue Care Revenue Forecast by Application (2019-2025) (USD Million)
